Mexiletine hydrochloride
 OpenBabel02212023462D

 14 13  0  0  0  0  0  0  0  0999 V2000
    0.0000    0.0000    0.0000 Cl  0  5  0  0  0  0  0  0  0  0  0  0
    2.2393    2.1577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9538    1.7452    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    3.6682    2.1577    0.0000 N   0  3  0  0  0  0  0  0  0  0  0  0
    2.9538    0.9202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6682    0.5077    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6682   -0.3173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3827   -0.7298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0972   -0.3173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3827   -1.5548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6682   -1.9673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9538   -1.5548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9538   -0.7298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2393   -0.3173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  7 13  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  0  0  0  0
 12 13  2  0  0  0  0
 13 14  1  0  0  0  0
M  CHG  2   1  -1   4   1
M  END
>  <CdId>
600

>  <Mol Weight>
215.72

>  <Formula>
C11H18ClNO

>  <ID>
T1046

>  <Name>
Mexiletine hydrochloride

>  <Synonyms>
KO1173

>  <CAS>
5370-01-4

>  <Approved status>
FDA

>  <Disease>
Cardiovascular system

>  <Indication>
Arrhythmias; Diabetic Neuropathies

>  <Pathways>
Membrane transporter/Ion channel; Metabolism

>  <Target>
AhR agonist; sodium channel inhibitor

>  <Receptor>
AhR; Voltage-gated sodium channel

$$$$
